COST-EFFECTIVENESS OF EPISODIC OR MAINTENANCE INFLIXIMAB VERSUS STANDARD TREATMENT IN AN INCIDENCE COHORT OF CROHN'S DISEASE PATIENTS WITH 10-YEARS FOLLOW-UP

被引：0
|
作者：
Odes, S. [1 ]
Greenberg, D. [2 ]
Vardi, H. [2 ]
Friger, M. [2 ]
Stockbrugger, R. [3 ]
Munkholm, P. [4 ,5 ]
机构：
[1] Soroka Med Ctr, IL-84101 Beer Sheva, Israel
[2] Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel
[3] Univ Hosp Maastricht, Maastricht, Netherlands
[4] Univ Copenhagen, Copenhagen, Denmark
[5] Herlev Hosp, Copenhagen, Denmark
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.772
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A329 / A330
页数：2
相关论文
共 50 条
  • [21] Cost-effectiveness of laparoscopic ileocecal resection versus infliximab treatment of terminal ileitis in Crohn's disease: the LIR!C TRIAL
    de Groof, J.
    Bemelman, W.
    Eshuis, E.
    Gardenbroek, T.
    Bossuyt, P.
    Bosmans, J.
    van Dongen, H.
    van Wagensveld, B.
    Brink, M.
    Consten, E.
    Buskens, C.
    D'Haens, G.
    Stokkers, P.
    Ponsioen, C.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S9 - S10
  • [22] Infliximab dependency in pediatric Crohn's disease: Long-term follow-up of an unselected cohort
    de Ridder, Lissy
    Rings, Edmond H. H. M.
    Damen, Gerard M.
    Kneepkens, C. M. Frank
    Schweizer, Joachim J.
    Kokke, Freddy T. M.
    Benninga, Marc A.
    Norbruis, Obbe F.
    Hoekstra, J. Hans
    Gijsbers, Carolien F. M.
    Escher, Johanna C.
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (03) : 353 - 358
  • [23] Incidence of Alzheimer's disease in India: A 10 years follow-up study
    Mathuranath, P. S.
    George, Annamma
    Ranjith, Neelima
    Justus, Sunita
    Kumar, M. Suresh
    Menon, Ramsekhar
    Sarma, P. Shankara
    Verghese, Joe
    NEUROLOGY INDIA, 2012, 60 (06) : 625 - 630
  • [24] Double balloon enteroscopy in paediatric Crohn's disease and 10 years follow-up
    Oba, J.
    Carlos, A.
    Azevedo, M.
    Milani, L.
    Freitas, N.
    Toma, R.
    Bibas, M.
    Damiao, A.
    Safatle-Ribeiro, A.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S253 - S253
  • [25] Evaluation of Treatment Patterns and Maintenance Dose Titration Among Patients With Crohn's Disease Initiating Biologics With 3 Years of Follow-Up
    Zhao, Ruizhi
    Ding, Zhijie
    Gupta, Parul
    Gozalo, Laurence
    Bruette, Robert
    Johnson, Victor M.
    Maughn, Keshia
    Liu, Yihang
    Kachroo, Sumesh
    JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCH, 2023, 10 (02): : 111 - 120
  • [26] Real-world cost-effectiveness associated with infliximab maintenance therapy for moderate to severe Crohn's disease in China
    Ji-Hao Shi
    Liang Luo
    Xiao-Li Chen
    Yi-Peng Pan
    Zhou Zhang
    Hao Fang
    Ying Chen
    Wen-Dong Chen
    Qian Cao
    World Journal of Gastroenterology, 2020, 26 (41) : 6455 - 6474
  • [27] Real-world cost-effectiveness associated with infliximab maintenance therapy for moderate to severe Crohn's disease in China
    Shi, Ji-Hao
    Luo, Liang
    Chen, Xiao-Li
    Pan, Yi-Peng
    Zhang, Zhou
    Fang, Hao
    Chen, Ying
    Chen, Wen-Dong
    Cao, Qian
    WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (41) : 6455 - 6474
  • [28] Cost-effectiveness of routine computerized tomography in follow-up of patients with complete response after primary treatment for Hodgkin's disease
    Guadagnolo, BA
    Punglia, RS
    Kuntz, KM
    Mauch, PM
    Ng, AK
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S114 - S115
  • [29] Surgery for Crohn's Disease: Results from a Spanish cohort with 15 years of follow-up
    Elosua Gonzalez, A.
    Rubio, S.
    Irisarri, R.
    Campillo, A.
    Nantes, O.
    Vicuna, M.
    Angos, R.
    Zozaya, J. M.
    Rodriguez, C.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 869 - 869
  • [30] Efficacy of Early Infliximab Treatment for Pediatric Crohn's Disease: A Three-year Follow-up
    Lee, Yun Seok
    Baek, Sang Hun
    Kim, Mi Jin
    Lee, Yoo Min
    Lee, Yoon
    Choe, Yon Ho
    PEDIATRIC GASTROENTEROLOGY HEPATOLOGY & NUTRITION, 2012, 15 (04) : 243 - 249
12345